Literature DB >> 6107134

Adaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits.

A E Raine, E M Vaughan Williams.   

Abstract

1 A method for measuring propranolol concentrations in plasma has been modified to permit estimations to be made on small volumes. The method has been used to correlate blockade of heart rate increases in response to intravenous isoprenaline, in both young and adult rabbits, with plasma concentrations of propranolol after subcutaneous injections of 2 or 4 mg/kg. It has been found that the relation between beta-adrenoceptor blockade and plasma concentrations is the same in rabbits as that determined by previous workers in man. 2 Adult Dutch dwarf rabbits were treated for 9 weeks twice daily subcutaneously with 2 mg/kg propranolol, or 10 mg/kg practolol, or with saline. 3 The treatment caused no change in heart weight in relation to body weight or in the water content of the hearts, in contrast to effects previously observed in young rabbits. 4 As in the young rabbits, treatment did cause a prolongation of action potential duration, as measured with intracellular electrodes in hearts of animals killed 24 h after the last dose of drug. 5 In another series of experiments, with a similar regime of treatment for 6 weeks, a significant reduction of diastolic blood pressure was observed in the propranolol group. 6 During the course of treatment and at the end, there was no change in the heart-rate increases observed in response to intravenous isoprenaline administered not less than 15 h after the previous dose of beta-blockers. Thus no functional alteration in sensitivity ot beta-adrenoceptor stimulation was apparent.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107134      PMCID: PMC2044330          DOI: 10.1111/j.1476-5381.1980.tb07926.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Plasma concentrations and the time-course of beta blockade due to propranolol.

Authors:  D G McDevitt; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

2.  Time required for complete recovery from chronic propranolol therapy.

Authors:  S L Faulkner; J T Hopkins; R C Boerth; J L Young; L V Jellett; A S Nies; H W Bender; D G Shand
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

3.  Cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  S Sen; R C Tarazi; P A Khairallah; F M Bumpus
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

4.  Hypertrophic obstructive cardiomyopathy in an infant--propranolol therapy for three years.

Authors:  D G Shand; C G Sell; J A Oates
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

5.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

6.  The almost complete hepatic extraction of propranolol during intravenous administration in the dog.

Authors:  D G Shand; G H Evans; A S Nies
Journal:  Life Sci I       Date:  1971-12-15

7.  Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels.

Authors:  J D Fitzgerald; B Scales
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1968

8.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

9.  Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade.

Authors:  A E Raine; T G Pickering
Journal:  Br Med J       Date:  1977-07-09

10.  Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.

Authors:  J D Fitzgerald; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

View more
  8 in total

Review 1.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

2.  Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  J Physiol       Date:  1984-10       Impact factor: 5.182

3.  Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.

Authors:  J H Botting; P Crook
Journal:  Experientia       Date:  1981-12-15

4.  The effect of prolonged propranolol administration on myocardial transmural capillary density in young rabbits.

Authors:  J Tasgal; E M Williams
Journal:  J Physiol       Date:  1981-06       Impact factor: 5.182

Review 5.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 6.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

7.  Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.

Authors:  I Ostman-Smith
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists.

Authors:  P Dennis; E M Vaughan Williams
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.